CRONOS GROUP INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
CRONOS GROUP INC. (CRON) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-02-26
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $0.00.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $25.65M, a 9.85% increase from fiscal 2023.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $23.35M, a 61.97% decline from fiscal 2022.
- CRONOS GROUP INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $61.39M.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $12.92M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $12.92M derived: sum of 3 quarters · filed 2026-02-26 | $25.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $12.92M derived: sum of 2 quarters · filed 2025-11-06 | $25.65M 10-Q · filed 2025-11-06 | $49.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $12.92M 10-Q · filed 2025-08-07 | $25.65M 10-Q · filed 2025-08-07 | $49.00M derived: sum of 3 quarters · filed 2026-02-26 | $49.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $12.73M 10-Q · filed 2025-05-08 | $36.08M derived: sum of 2 quarters · filed 2026-02-26 | $36.08M derived: sum of 3 quarters · filed 2026-02-26 | $36.08M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $23.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.35M derived: sum of 2 quarters · filed 2026-02-26 | $23.35M derived: sum of 3 quarters · filed 2026-02-26 | $23.35M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $21.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $21.18M derived: sum of 3 quarters · filed 2025-02-27 | $50.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $21.18M derived: sum of 2 quarters · filed 2025-02-27 | $50.15M derived: sum of 3 quarters · filed 2025-02-27 | $50.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $21.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $50.15M derived: sum of 2 quarters · filed 2025-02-27 | $50.15M derived: sum of 3 quarters · filed 2025-02-27 | $61.39M 10-K · filed 2025-02-27 |
| 2022-09-30 | $28.97M 10-Q · filed 2023-11-08 | $28.97M derived: sum of 2 quarters · filed 2023-11-08 | $40.21M 10-Q · filed 2023-11-08 | $40.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $11.24M 10-Q · filed 2023-08-08 | $11.24M derived: sum of 3 quarters · filed 2024-02-29 | $11.24M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $11.24M 10-Q · filed 2023-05-09 | $11.24M derived: sum of 2 quarters · filed 2024-02-29 | $11.24M derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |